BrightSpring Health Services, Inc. (BTSG)
(Real Time Quote from BATS)
$11.98 USD
+0.02 (0.17%)
Updated Jul 23, 2024 11:24 AM ET
2-Buy of 5 2
A Value B Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BTSG 11.98 +0.02(0.17%)
Will BTSG be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for BTSG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BTSG
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
Wall Street Analysts Think BrightSpring Health Services, Inc. (BTSG) Could Surge 38.15%: Read This Before Placing a Bet
BTSG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BTSG
IPO Roundup: Lineage, OneStream Software, and more
Wall Street Breakfast: The Week Ahead
BrightSpring Health Services Earns Multiple Accreditations Across the Country for Quality Care
BrightSpring Health Services, Inc. to Announce Second Quarter 2024 Financial Results on August 2, 2024
BrightSpring Health’s Strategic Acquisitions and Organic Growth Garner a Buy Rating